Limited Competition for the Continuation of the Diabetes Prevention Program Outcomes Study (DPPOS) Biostatistics Research Center (Collaborative U01)
Funding Opportunity RFA-DK-15-505 from the NIH Guide for Grants and Contracts. The purpose of this Limited Competition Funding Opportunity Announcement (FOA) is to continue follow-up of the Diabetes Prevention Program Outcomes Study (DPPOS) cohort through a collaborative cooperative agreement. The Diabetes Prevention Program (DPP) was a multi-center controlled clinical trial examining the efficacy of treatments to prevent or delay the development of type 2 diabetes in a population at high risk. The DPP demonstrated that either lifestyle change or the drug metformin could reduce the development of type 2 diabetes by 5...
Source: NIH Funding Opportunities (Notices, PA, RFA) - February 6, 2015 Category: Research Source Type: funding
Request for Expressions of Interest: Exploratory Clinical Trials of Non-insulin Adjunct Therapies in Type 1 Diabetes
Expression of Interest Deadline: July 11, 2014 JDRF, the world’s leading non-profit organization with the mission to cure, treat and prevent type 1 diabetes (T1D), invites Expressions of Interest (EOI) for clinical trials to evaluate non-insulin based adjunct therapies for improved glycemic and overall metabolic control of T1D. JDRF has an unprecedented opportunity to make progress in the clinical assessment of adjunctive therapies for T1D that move beyond an insulin-centric view of the disease. At present, several agents–mostly approved T2D therapies such as incretins, SGLT inhibitors, metform...
Source: ScanGrants feed - May 27, 2014 Category: Research Authors: JDRF Source Type: funding
Limited Competition: Continuation of the Type 2 Diabetes in Adolescents and Youth (TODAY) Study (U01)
Funding Opportunity Number: RFA-DK-14-502 Opportunity Category: DiscretionaryFunding Instrument Type: Cooperative AgreementCategory of Funding Activity: Food and NutritionHealthCFDA Number: 93.847Eligible Applicants Others (see text field entitled "Additional Information on Eligibility" for clarification)Agency Name: HHS-NIH11Closing Date: Jun 19, 2014Award Ceiling: $10,000,000Expected Number of Awards: 1Creation Date: Mar 21, 2014Funding Opportunity Description: The purpose of this Funding Opportunity Announcement (FOA) is to continue follow-up of the Treatment Options for Type 2 ...
Source: Grants.gov - March 21, 2014 Category: Research Tags: Food and Nutrition Health Source Type: funding
Limited Competition: Continuation of the Type 2 Diabetes in Adolescents and Youth (TODAY) Study (U01)
Funding Opportunity RFA-DK-14-502 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to continue follow-up of the Treatment Options for Type 2 Diabetes in Adolescents and Youth (TODAY) cohort through a cooperative agreement. TODAY was a multi-center controlled clinical trial examining the efficacy of three approaches to treat recently diagnosed type 2 diabetes in youth ages 10-17 years. TODAY demonstrated that combination therapy with metformin plus rosiglitazone sustained glycemic control longer than either metformin plus an intensive lifestyle program or metfo...
Source: NIH Funding Opportunities (Notices, PA, RFA) - March 21, 2014 Category: Research Source Type: funding
Limited Competition for the Continuation of the Diabetes Prevention Program Outcomes Study (DPPOS) (U01)
Funding Opportunity Number: RFA-DK-14-501 Opportunity Category: DiscretionaryFunding Instrument Type: Cooperative AgreementCategory of Funding Activity: Food and NutritionHealthCFDA Number: 93.847Eligible Applicants Others (see text field entitled "Additional Information on Eligibility" for clarification)Agency Name: HHS-NIH11Closing Date: May 28, 2014Award Ceiling: $400,000Expected Number of Awards: 23Creation Date: Mar 12, 2014Funding Opportunity Description: The purpose of this Limited Competition Funding Opportunity Announcement (FOA) is to continue follow-up of the Diabetes Pr...
Source: Grants.gov - March 13, 2014 Category: Research Tags: Food and Nutrition Health Source Type: funding
Limited Competition for the Continuation of the Diabetes Prevention Program Outcomes Study (DPPOS) (U01)
Funding Opportunity RFA-DK-14-501 from the NIH Guide for Grants and Contracts. The purpose of this Limited Competition Funding Opportunity Announcement (FOA) is to continue follow-up of the Diabetes Prevention Program Outcomes Study (DPPOS) cohort through a cooperative agreement. The Diabetes Prevention Program (DPP) was a multi-center controlled clinical trial examining the efficacy of treatments to prevent or delay the development of type 2 diabetes in a population at high risk. The DPP demonstrated that either lifestyle change or the drug metformin could reduce the development of type 2 diabetes by 58% and 31%, re...
Source: NIH Funding Opportunities (Notices, PA, RFA) - March 12, 2014 Category: Research Source Type: funding
